Thomas Willigenburg

MD PhD MSc, Radiation Oncologist in training, Epidemiologist @UMCUtrecht with a focus on MR-guided SBRT for (recurrent) prostate cancer

[Elekta @Elekta]

With the ERECT trial, @UMCUtrecht researchers hypothesize that lowering the dose to structures crucial in achieving and maintaining an erection could preserve function. Men with #prostatecancer who are recruited receive tx with how many fx of 7.25 Gy with Elekta Unity? #MRgRT

[Alison Tree 💙 @alison_tree]

Great talk by @Mat_Guc at the Turkish UROK conference. Always shocking to be reminded how little of the global cancer research spend goes on the treatments that cure most patients. Imagine what radonc could achieve with a level playing field #radonc

[Thomas Willigenburg @TWilligenb]

@GemeenteUtrecht Wat een zure reactie ‘AK’. Feedback kun je ook ter harte nemen en er het beste uithalen; je krijgt het niet voor niets. Op deze manier boek je nooit vooruitgang.

[Thomas Willigenburg @TWilligenb]

@GemeenteUtrecht we vinden het heel fijn dat jullie ons informeren, maar waarom per brief? Snoeien jullie deze boom om er vervolgens weer nieuw briefpapier van te kunnen maken? Niet zo duurzaam… zonde van het papier en de kosten. Gewoon een digitaal berichtje in het vervolg? 🙏🏼

[Thomas Willigenburg @TWilligenb]

This Thursday, Jan 26th, I will defend my PhD thesis ‘MRI-guided radiotherapy for localised prostate cancer’. Thanks to my promotor @JJWLagendijk and all and collaborators over the past years! @UMCUtrecht @Cancer_UMCU @Elekta @FreekTeunissen https://t.co/6PdRnTsoKd

[Freek Teunissen @FreekTeunissen]

We just published the first largest series of outcomes of patients treated with 5x7.25Gy MRgRT for localized prostate cancer on the 1.5T MR-Linac. Results from the MOMENTUM study: an international registry for the evidence-based introduction of MRgRT.(1/n)
https://t.co/cZb1QpGn2M

[Radiotherapy & Oncology @RO_GreenJournal]

New article alert Vol. 176

Clinical application of a sub-fractionation workflow for intrafraction re-planning during prostate RT treatment on a 1.5 Tesla MR-Linac
T. Willigenburg et al.
https://t.co/yD4IbqSdT3

https://t.co/HrIarAgvTq

[Radiotherapy & Oncology @RO_GreenJournal]

New article alert Vol. 171

Thomas Willigenburg et al.
Accumulated bladder wall dose is correlated with patient-reported acute urinary toxicity in prostate cancer patients treated with stereotactic, daily adaptive MR-guided rt.
https://t.co/iSA8dIHKdo

https://t.co/lmCq7LuEnF

[Sean Collins Prostate SBRT @ USF Health @SbrtSean]

Accumulated bladder wall dose is correlated with patient-reported acute urinary toxicity in prostate cancer patient… https://t.co/hiQzTw1Zzb